From: New challenges for microRNAs in acute pancreatitis: progress and treatment
Molecular marker | Expression | Patient | Clinical relevance | References |
---|---|---|---|---|
miR-92b, miR-10a, miR-7 | Up | AP | Diagnosis | [67] |
miR-551-5p, miR-126a-5p | Up | AP | Severity assessment | |
miR-24-3p, miR-222-3p, miR-361-5p and miR-1246 | Up | HTAP | Severity assessment | [71] |
miR-181a-5p | Down | HTAP | Severity assessment | [71] |
miR-22-3p, 1260b, miR-762, miR-23b and miR-23a | Up | AP with ALI | Diagnosis, prognosis | [72] |
miR-550a*, miR-324-5p, miR-484, miR-331-3p, miR-22-3p, miR-140-3p and miR-342-3p | Down | AP with ALI | Diagnosis, prognosis | [72] |
miR-146a, miR-146b | Up | AP | Prognosis | [73] |
miR-192-5p | Down | AP with NAFLD | Diagnosis | [74] |
miR-372 | Up | HTGAP | Diagnosis, prognosis | [75] |
miR-29a | Up | AP | Severity assessment, prognosis | [76] |
miR-7, miR-9, miR-122 and miR-141 | Up | AP | Diagnosis, prognosis | [77] |
miR-155, miR-21 | Down | AP | Diagnosis, severity assessment, prognosis | [78] |
miR-127 | Down | AP with ALI | Diagnosis, severity assessment, prognosis | [79] |
miR-216 | Up | AP | Diagnosis, severity assessment | [80] |